Penumbra (PEN) Other Non Operating Income (2014 - 2023)
Penumbra's (PEN) quarterly Other Non Operating Income came in at -$444000.0 in Q3 2023, up 81.15% year-over-year from -$245094.7 in Q3 2022, and down 154.95% quarter-over-quarter from $808000.0 in Q2 2023.
Analysis
Penumbra (PEN) Other Non Operating Income (2014 - 2023) Analysis & Trends
Penumbra (PEN) has reported Other Non Operating Income for 10 consecutive years, with -$444000.0 the latest figure, recorded in Q3 2023.
- On a quarterly basis, Other Non Operating Income rose 81.15% year-over-year to -$444000.0 in Q3 2023; TTM through Sep 2023 was $2.4 million, a 146.75% increase from a year earlier, with the FY2022 full-year figure at -$2.3 million, up 40.92% from the prior year.
- Other Non Operating Income was -$444000.0 for Q3 2023 at Penumbra, down from $808000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $2.0 million in Q4 2022 and troughed at -$2.4 million in Q3 2022.
- A 5-year average of -$335894.7 and a median of -$408000.0 in 2021 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income soared 1445.45% in 2019 and tumbled 8221.43% in 2021, its largest moves.
- Over 5 years, Other Non Operating Income stood at $592000.0 in 2019, then soared by 32.94% to $787000.0 in 2020, then slumped by 216.65% to -$918000.0 in 2021, then jumped by 317.43% to $2.0 million in 2022, then plunged by 122.24% to -$444000.0 in 2023.
- The last three Other Non Operating Income figures came in at -$444000.0 (Q3 2023), $808000.0 (Q2 2023), and $90000.0 (Q1 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.91 Bn | 178.31 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.32 Bn | 119.11 Bn | 1.96 Bn |
| 3 | Medtronic | 118.42 Bn | 109.60 Bn | 6.34 Bn |
| 4 | Stryker | 105.22 Bn | 101.74 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.57 Bn | 66.03 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.76 Bn | 45.51 Bn | 1.35 Bn |
| 7 | Alcon | 33.91 Bn | 32.46 Bn | 1.68 Bn |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn |
| 9 | Steris | 21.10 Bn | 20.62 Bn | 684.20 Mn |
| 10 | Penumbra | 12.58 Bn | 11.93 Bn | 264.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -444,000.00 |
| Jun 30, 2023 | 808,000.00 |
| Mar 31, 2023 | 90,000.00 |
| Dec 31, 2022 | 2.00 Mn |
| Sep 30, 2022 | -2.36 Mn |
| Jun 30, 2022 | -956,000.00 |
| Mar 31, 2022 | -1.01 Mn |
| Dec 31, 2021 | -918,000.00 |
| Sep 30, 2021 | -1.14 Mn |
| Jun 30, 2021 | -408,000.00 |
| Mar 31, 2021 | -1.48 Mn |
| Dec 31, 2020 | 787,000.00 |
| Sep 30, 2020 | 14,000.00 |
| Jun 30, 2020 | 511,000.00 |
| Mar 31, 2020 | -1.66 Mn |
| Dec 31, 2019 | 592,000.00 |
| Sep 30, 2019 | -772,000.00 |
| Jun 30, 2019 | -71,000.00 |
| Mar 31, 2019 | 24,000.00 |
| Dec 31, 2018 | -44,000.00 |